![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » EVOTEC REACHES FIRST MILESTONE AND RECEIVES SUCCESS PAYMENT IN COLLABORATION WITH TAKEDA
EVOTEC REACHES FIRST MILESTONE AND RECEIVES SUCCESS PAYMENT IN COLLABORATION WITH TAKEDA
December 6, 2005
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX 30, "Evotec") announced today that the first milestone has been achieved in its four-year drug discovery collaboration with Takeda Pharmaceutical Company Limited (Osaka, Japan, "Takeda"). Evotec has granted Takeda exclusive rights in a novel target in Alzheimer's disease based on successful target identification and validation work triggering a milestone payment of a few millions Euro.
Biotech Intelligence (http://www.biotech-intelligence.com/html/html/6dc2c0f2af44ac21d5e3de6932f75a33.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct